Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

By J. Tardif, J. Grégoire, P. L’allier, R. Ibrahim, J. Lésperance, T. Heinonen, S. Kouz, C. Berry, R. Basser, M. Lavoie and 2 more. Journal of the American Medical Association (JAMA), 2007

728 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/4b8f93a289477f8526dcd9747aab07f32ed523d8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Peter Libby
2. G. Hansson
3. P. Ridker
4. L. Melvin
5. A. Lichtman
6. I. Tabas

In Pulmonary and Respiratory Medicine

1. P. Ridker

In Surgery

1. Peter Libby
2. G. Hansson
3. P. Ridker
4. I. Tabas
5. L. Melvin
6. Jongsoon Lee
7. K. Bornfeldt
8. A. Lichtman

Citations in the corpus

• Progress and challenges in translating the biology of atherosclerosis (2011, background): “Apolipoprotein A-I (Apo-AI), the major protein component of HDL, has received much attention as a possible therapeutic target for atherosclerosi”